La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Applied Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Applied Therapeutics..

Applied Therapeutics (NASDAQ:APLT) Azioni, Catena delle Opzioni

APPLIED THERAPEUTICS INC

Applied Therapeutics

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics Inc

Health Care

Press Releases

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

News

Management

Applied Therapeutics Announces Key Leadership Appointments

Earnings

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Legal

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf

Penny Stocks

Applied Therapeutics Provides Update Following Meeting with FDA

Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

APLT

IBTA

LFMD

LNTH

LUXH

QMCO

SVRA

TMCI

UNCY

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Alector

Anika Therapeutics

Anixa Biosciences

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Compugen

Coherus Oncology

Climb Bio

Cardiff Oncology

Citius Oncology

Elicio Therapeutics

Fate Therapeutics

Forte Biosciences

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Seres Therapeutics

MDxHealth

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Nuvectis Pharma

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Spero Therapeutics

Vor Biopharma

RBC Capital

Citigroup

Baird

Leerink Partners

Comments

Applied Therapeutics

Applied Therapeutics (APLT) Opzioni

Applied Therapeutics (NASDAQ:APLT) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO